Short Interest Report: What’s Next for Cryoport Incorporated (NASDAQ:CYRX) After Having Less Shares Shorted?

December 1, 2016 - By Linda Rogers   ·   0 Comments

Short Interest Report: What's Next for Cryoport Incorporated (NASDAQ:CYRX) After Having Less Shares Shorted?

The stock of Cryoport Incorporated (NASDAQ:CYRX) registered a decrease of 15.7% in short interest. CYRX’s total short interest was 139,100 shares in December as published by FINRA. Its down 15.7% from 165,000 shares, reported previously. With 14,200 shares average volume, it will take short sellers 10 days to cover their CYRX’s short positions. The short interest to Cryoport Incorporated’s float is 0.98%. The stock decreased 3.40% or $0.08 on November 30, hitting $2.27. CryoPort Inc (NASDAQ:CYRX) has declined 6.20% since April 28, 2016 and is downtrending. It has underperformed by 12.12% the S&P500.

Cryoport, Inc. is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The company has a market cap of $40.29 million. The Firm provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients. It currently has negative earnings. The Company’s Cryoport Express Solution includes a cloud logistics operating platform, which is branded as the Cryoportal.

CYRX Company Profile

Cryoport, Inc. (Cryoport), incorporated on May 25, 1990, is a well-known provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Firm provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients. The Company’s clients include companies and institutions that require cryogenic logistics solutions, such as therapy developers for personalized medicine, bio-pharmaceuticals, research, contract research organizations, diagnostic laboratories, contract manufacturers, cord blood repositories, vaccine manufacturers, animal husbandry related companies and in-vitro fertilization clinics.

More notable recent CryoPort Inc (NASDAQ:CYRX) news were published by: Prnewswire.com which released: “Cryoport Expands Agreement with Stemedica to Support a Phase II Clinical Trial …” on August 11, 2016, also Streetinsider.com with their article: “Cryoport, Inc. (CYRX) Prices 2M Public Offering at $3.25/Unit” published on July 24, 2015, Seekingalpha.com published: “A Shareholder’s Concern With Cryoport’s Corporate Governance” on November 09, 2016. More interesting news about CryoPort Inc (NASDAQ:CYRX) were released by: Quotes.Wsj.com and their article: “CryoPort Inc. CYRX (US: Nasdaq)” published on February 15, 2011 as well as Seekingalpha.com‘s news article titled: “Cryoport offers warrant holders special deal to raise capital” with publication date: August 12, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Linda Rogers


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>